Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. Meropenem - Vaborbactam
2. Meropenem And Vaborbactam
3. Meropenem Vaborbactam Drug Combination
4. Vabomere
1. Meropenem & Vaborbactam
2. Meropenem + Vaborbactam
3. 2031124-72-6
4. Vabomere
5. Meropenem / Vaborbactam
6. Meropenem And Vaborbactam
7. Meropenem Mixture With Vaborbactam
8. (4r,5s,6s)-3-[(3s,5s)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid;2-[(3r,6s)-2-hydroxy-3-[(2-thiophen-2-ylacetyl)amino]oxaborinan-6-yl]acetic Acid
Molecular Weight | 680.6 g/mol |
---|---|
Molecular Formula | C29H41BN4O10S2 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 13 |
Rotatable Bond Count | 10 |
Exact Mass | 680.2357160 g/mol |
Monoisotopic Mass | 680.2357160 g/mol |
Topological Polar Surface Area | 260 Ų |
Heavy Atom Count | 46 |
Formal Charge | 0 |
Complexity | 1050 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DH - Carbapenems
J01DH52 - Meropenem and vaborbactam
Global Sales Information
Market Place
Reply
30 Nov 2024
Reply
29 Aug 2022
Reply
29 Dec 2020
Reply
16 May 2020
ABOUT THIS PAGE
A Meropenem And Vaborbactam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Meropenem And Vaborbactam, including repackagers and relabelers. The FDA regulates Meropenem And Vaborbactam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Meropenem And Vaborbactam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Meropenem And Vaborbactam supplier is an individual or a company that provides Meropenem And Vaborbactam active pharmaceutical ingredient (API) or Meropenem And Vaborbactam finished formulations upon request. The Meropenem And Vaborbactam suppliers may include Meropenem And Vaborbactam API manufacturers, exporters, distributors and traders.
Meropenem And Vaborbactam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Meropenem And Vaborbactam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Meropenem And Vaborbactam GMP manufacturer or Meropenem And Vaborbactam GMP API supplier for your needs.
A Meropenem And Vaborbactam CoA (Certificate of Analysis) is a formal document that attests to Meropenem And Vaborbactam's compliance with Meropenem And Vaborbactam specifications and serves as a tool for batch-level quality control.
Meropenem And Vaborbactam CoA mostly includes findings from lab analyses of a specific batch. For each Meropenem And Vaborbactam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Meropenem And Vaborbactam may be tested according to a variety of international standards, such as European Pharmacopoeia (Meropenem And Vaborbactam EP), Meropenem And Vaborbactam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Meropenem And Vaborbactam USP).
LOOKING FOR A SUPPLIER?